SAGE Journals

Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria

Posted on 2022-12-18 - 01:12

Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) and type 2 diabetes (T2D) populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Services (CMS) ignore the conclusive evidence that supports CGM use in various diabetes populations that are currently deemed ineligible. In an earlier article, we discussed the limitations and inconsistencies of the agency’s CGM eligibility criteria relative to current scientific evidence and proposed practice solutions to address this issue and improve the safety and care of Medicare beneficiaries with diabetes. Although Medicaid is administered through CMS, there is no consistent Medicaid policy for CGM coverage in the United States. This article presents a rationale for modifying and standardizing Medicaid CGM coverage eligibility across the United States.


Select your citation style and then place your mouse over the citation text to select it.



Usage metrics

Journal of Diabetes Science and Technology


Rodolfo J. Galindo
Grazia Aleppo
Christopher G. Parkin
David A. Baidal
Anders L. Carlson
Eda Cengiz
Gregory P. Forlenza
Davida F. Kruger
Carol Levy
Janet B. McGill
Guillermo E. Umpierrez
need help?